Summary of all studies containing PUBCHEM ID 5282775
Project | Study | Study_title | Subject_type | Subject_species | Metabolite_name |
---|---|---|---|---|---|
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid C12 PARENT [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-1 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-10 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-11 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-12 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-13 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-14 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-15 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-16 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-17 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-18 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-19 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-2 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-20 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-21 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-22 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-23 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-24 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-25 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-26 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-27 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-28 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-29 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-3 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-30 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-31 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-32 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-33 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-34 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-35 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-36 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-37 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-38 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-39 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-4 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-40 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-41 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-42 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-43 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-44 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-45 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-46 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-47 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-48 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-49 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-5 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-50 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-6 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-7 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-8 [Data] |
PR001941 | ST003151 | BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 | Cultured cells | Homo sapiens | Ximenic acid D-label-9 [Data] |
PR001511 | ST002354 | Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. | Mammal | Rattus norvegicus | Hexacosenoic acid [Data] |